Anticancer peptide A2
Not For Human Use, Lab Use Only.
Cat.#: 302567
Special Price 164.50 USD
-
Product Name
Anticancer peptide A2
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
GLFDKLKSLVSDF
-
Sequence
Gly-Leu-Phe-Asp-Lys-Leu-Lys-Ser-Leu-Val-Ser-Asp-Phe
-
Length (aa)
13
-
Peptide Purity (HPLC)
97.8%
-
Source
Synthetic
-
Form
Powder
-
Description
Anticancer peptide A2 is a designed cationic peptide derived from the N-terminal sequence of the Escherichia coli enzyme IIAGlc membrane anchor. It adopts a disordered conformation in aqueous solution but forms an amphipathic α-helical structure in membrane-mimetic environments such as SDS micelles, as demonstrated by circular dichroism spectroscopy. The three-dimensional NMR structure reveals a distinct hydrophobic surface, enabling deeper membrane penetration compared to the nontoxic parental peptide. Key structural features include a broader hydrophobic face and interfacial basic residues, which contribute to its membrane-interactive properties.
The peptide's sequence (GLFDKLKSLVSDF) incorporates a Phe13 substitution and C-terminal truncation relative to the original membrane anchor. NMR-derived structural analysis indicates that A2 lacks strong salt bridges but possesses a well-defined helical segment spanning residues Leu2-Ser11. Its membrane activity is linked to the presence of hydrophobic patches bordered by cationic residues, a characteristic shared with other bioactive peptides in the GLFD family. The structural attributes of A2 provide insights into the role of sequence modifications in modulating membrane interactions.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Wang G, Li Y, Li X. Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor. J Biol Chem. 2005 Feb 18;280(7):5803-11. doi: 10.1074/jbc.M410116200. Epub 2004 Nov 30. PMID: 15572363.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
-
Molar Concentration Calculator
-
Dilution Calculator
-
Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"